---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-017145"
form_type: "8-K/A"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2026-04-17T23:59:59+00:00"
generated_at: "2026-05-15T05:35:07.525725+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aspire Biopharma closes second tranche of $21M preferred offering; funds Dura Driver acquisition

## Summary
- Closed second tranche of Series A Convertible Preferred stock on April 15, 2026 for 12,500 shares and gross proceeds of ~$10M.
- Combined with first tranche (13,750 shares, $11M), total offering raises $21M before fees.
- Amended Certificate of Designation to increase authorized Series A shares from 25,000 to 30,000.
- Net proceeds to fund cash portion of proposed Dura Driver Control Systems acquisition and for general corporate purposes.
- RBW Capital Partners acting through Dawson James Securities acted as placement agent.

## SEC filing metadata
- accession: 0001493152-26-017145
- form_type: 8-K/A
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2026-04-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315226017145/0001493152-26-017145-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315226017145/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-017145
- JSON: https://secwatch.observer/filing/0001493152-26-017145.json
- Plain text: https://secwatch.observer/filing/0001493152-26-017145.txt

## Key facts
- Governance Changes
  Aspire Biopharma Holdings, Inc.: On April 13, 2026, the Company filed a Certificate of Amendment to the Certificate of Designation of Series A Convertible Preferred Stock, amending provisions including the designation and number of shares, designating 30,000 shares with a par value of $0.0001 and a stated value of $1,000 per share (effective 2026-04-13).
  - Change: charter amendment
  - Effective: 2026-04-13
  source text: On April 13, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Certificate of Designation of Series A Convertible Preferred Stock (the “ Certificate of Amendment ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1847345/000149315226017145/0001493152-26-017145-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.